Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-01-12Optimizing Treatment for Schizophrenic Smokers
-
CLINICAL_TRIALS study record update · 2017-01-12Transdermal Nicotine and Bupropion-SR in Schizophrenics (Study 2)
-
CLINICAL_TRIALS study record update · 2017-01-11Nicotine and Smoking Cessation in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-01-10Rehabilitation, Brain Function and Early Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-01-09Pregablin for Anxiety-comorbidity in Patients With Schizophrenia - a Double-blinded Randomized Placebo Controlled Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-01-05Novel EtG-Based Contingency Management for Alcohol in the Severely Mentally Ill
-
CLINICAL_TRIALS study record update · 2016-12-30Phase I, Single-center, Inpatient, Randomized, Double-blind, Placebo-controlled, Dose Escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profiles of Single Oral Doses of AVL-3288 (Anvylic-3288) Healthy Subjects.
-
CLINICAL_TRIALS study record update · 2016-12-30A Pilot Study for the Treatment of Refractory Auditory Verbal Hallucinations With Transcranial Direct Current Stimulation(tDCS) in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2016-12-19MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications
-
CLINICAL_TRIALS study record update · 2016-12-16Effects of F17464 in Acute Exacerbation of Schizophrenia
-
CLINICAL_TRIALS study record update · 2016-12-13A Multi-center, Double-blind, Flexible-dose Efficacy Trial With Org 25935 Versus Placebo as add-on Therapy in Subjects With Predominant, Persistent Negative Symptoms of Schizophrenia Treated With a Stable Dose of a Second Generation Antipsychotic (GIANT)
-
CLINICAL_TRIALS study record update · 2016-12-08Influence of Magnesium Variations (Serum and Intra-erythrocyte) on Markers of Cardiometabolic Risk in Long-term Prescription of Antipsychotic Drugs: a Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2016-12-01A Double Blind Placebo Controlled Study of Valaciclovir in Treatment of Psychosis in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2016-11-29The Impact of Yoga Supplementation on Cognitive Function Among Indian Outpatients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2016-11-28Multicenter Study on Factors Influencing Real-life Social Functioning of People With a Diagnosis of Schizophrenia
-
CLINICAL_TRIALS study record update · 2016-11-17Enhancing Assertive Community Treatment With Cognitive Behavioral Therapy and Social Skills Training for Schizophrenia.
-
CLINICAL_TRIALS study record update · 2016-11-17Specificity and Generalizability of Cognitive Remediation and Functional Skills Training in Schizophrenia
-
CLINICAL_TRIALS study record update · 2016-11-16Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2016-11-10Neuroendocrine, Metabolite Substrates, Clinical Symptoms and Cognitive Function in Schizophrenia
-
CLINICAL_TRIALS study record update · 2016-11-09Effects of NMDA Receptor Antagonism on Cognitive Processes in Healthy Volunteers and Its Reversal by a Dopamine Antagonist: Comparison to Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2016-11-08Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill
-
CLINICAL_TRIALS study record update · 2016-11-08A Double-blind, Randomised, Parallel-group, Placebo-controlled Study of the Safety, Tolerability and Efficacy Following Sequential Dose Regimens of Lu 31-130 to Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2016-11-08A Randomised, Double-blind, Parallel-Group, Fixed Dose Study Exploring the Efficacy and Safety of Lu AE58054 as Augmentation Therapy to Risperidone in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2016-11-08A Prospective, Open-label, Single-arm, Multinational, Multi-centre, Flexible-dose, Extension Study of the SCoP 99824 With Sertindole for Patients Suffering From Schizophrenia
-
CLINICAL_TRIALS study record update · 2016-11-08A Randomised, Double-blind, Parallel-group, Active-controlled, Flexible Dose Study Exploring the Efficacy and Safety of 12 Weeks Treatment With Lu 31-130 in Patients With Schizophrenia